原发性胃非霍奇金淋巴瘤的研究进展  

Research progress of primary gastric tract non-Hodgkin lymphoma

作　　者：马莉[1] 苏丽萍[1] 

机构地区：[1]山西医科大学附属肿瘤医院血液病诊疗中心,太原030013

出　　处：《白血病．淋巴瘤》2015年第5期311-314,共4页Journal of Leukemia & Lymphoma

摘　　要：原发性胃淋巴瘤（PGL）是一种较为少见的淋巴瘤,组织学类型主要是非霍奇金淋巴瘤.其临床表现无特异性,胃镜为目前主要的诊断手段,CT、PET-CT及骨髓检查常被用于进行分期.对于PGL的治疗,近年来逐渐向非手术治疗发展.淋巴瘤是对化疗敏感的肿瘤,常规化疗方案有效率达60％～80％,手术治疗多用于胃出血、穿孔等并发症.Primary gastric lymphoma （PGL） is a rare cancer of the stomach,and the most common type is non-Hodgkin lymphoma.The clinical feature of PGL has no specificity.Gastroscope is the current main mean for diagnosis,and CT,PET-CT and bone marrow examination are often used in staging.The treatment of PGL in recent years gradually turns to nonoperative treatment.Lymphoma is sensitive to chemotherapy,effective rate of conventional chemotherapy regimens is 60 %-80 %,and surgery is usually used for stomach bleeding and perforation of the complications.

关 键 词：淋巴瘤 非霍奇金 胃 诊断 治疗 

分 类 号：R735[医药卫生—肿瘤]